IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ally Bridge Group (NY) LLC

Portfolio Profile

CIK: 0001822947 | NEW YORK, NY

Investment Profile

Style

Deep Value

Turnover

Very High

Orientation

Concentrated trader
$77.6M
AUM
23
Positions
64.83%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Minerva Neurosciences Inc(NERV)2,175,802$12.1M10.68%
2Promis Neurosciences Inc(PMN)620,319$8.2M7.22%
3First Tracks Biotherapeutics(TRAX)284,287$5.7M5.06%
4Axsome Therapeutics Inc(AXSM)16,493$4.0M3.57%
5Assembly Biosciences Inc(ASMB)140,000$3.8M3.40%

Sector Allocation

Latest filing, equity positions only

Healthcare78.83% · $61.2M
Unclassified21.17% · $16.4M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare91.16%78.83%-12.33%
Unclassified8.84%21.17%+12.33%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$85.2M | 19 pos.
$167.8M | 22 pos.
$179.9M | 22 pos.
$167.9M | 25 pos.
$186.8M | 29 pos.
$116.6M | 30 pos.
6
Whitehawk Therapeutics Inc(WHWK)
817,939
$3.7M
3.31%
7Edgewise Therapeutics Inc(EWTX)83,300$3.4M2.99%
8Climb BIO Inc(CLYM)249,172$3.2M2.87%
9Kura Oncology Inc(KURA)290,000$3.2M2.81%
10Cytomx Therapeutics Inc.(CTMX)775,000$2.9M2.57%
Cap SizePrev %Curr %Change
Small Cap49.58%44.36%-5.22%
Unclassified8.84%21.17%+12.33%
Micro Cap13.02%18.89%+5.87%
Mid Cap28.56%15.58%-12.98%
$110.9M | 28 pos.
$120.2M | 24 pos.
$164.2M | 25 pos.
$96.0M | 20 pos.
$123.8M | 28 pos.
$113.1M | 25 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

12
New
14
Closed
2
Increased
9
Decreased
2
Unchanged